Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 17,485 $ 3,333
Short term cash deposits 30,074
Trade receivables 277 830
Other accounts receivable and prepaid expenses 979 239
Restricted deposit 12 12
Inventory 940 1,262
Total current assets 49,767 5,676
Non-current assets:    
Restricted deposit 178 181
Operating lease right-of-use assets 2,792 2,796
Property and equipment, net 2,119 2,106
Intangible assets 164 82
Total non-current assets 5,253 5,165
Total assets 55,020 10,841
Accounts payable:    
Trade payables 698 798
Accrued liabilities and other 1,584 1,943
Operating lease liabilities 651 440
Deferred revenues 207
Total current liabilities 2,933 3,388
Non-current liabilities:    
Derivatives liability 28
Operating lease liabilities 2,649 2,948
Total non-current liabilities 2,649 2,976
Total liabilities 5,582 6,364
Commitments and contingencies
Shareholders’ Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2021 and December 31, 2020; issued and outstanding: 10,258,129 and 6,963,838 ordinary shares as of June 30, 2021 and December 31, 2020, respectively 4,448 2,933
Additional paid in capital 111,907 75,547
Currency translation differences (969) (969)
Accumulated deficit (65,948) (73,034)
Total shareholders’ equity 49,438 4,477
Total liabilities and shareholders’ equity $ 55,020 $ 10,841